Zaprinast

Catalog #
27218
$110 *
Size: 10 mg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Zaprinast is a cGMP-specific PDE inhibitor which moderately inhibits PDE5 and PDE6. It weakly inhibits PDE9, PDE10 and PDE11. Sildenafil (Viagra™) was developed from Zaprinast, which enhances the vasodilatory effects of nitric oxide in a range of vascular tissues by prolonging the cGMP-mediated activation of cGMP-dependent protein kinase. Also, GPR35 is activated by Zaprinast.

Product Info
Storage and Usage
Citations
Purity

≥98% by HPLC

Format
A crystalline solid.
Formula
C13H13N5O2
MW
271.3 Da
Solubility
Soluble in DMSO and DMF, purged with an inert gas. Solubility in DMSO and DMF is ~10 mg/ml. For maximum solubility, dissolve in DMF and then dilute with the aqueous buffer of choice.
Biological Activity
Zaprinast inhibits PDE5 and PDE6 with IC50 values of 0.5-0.76 µM and 0.15 µM, respectively.
CAS Registry #
37762-06-4
References
1. Nakamizo, T., et al., J. Neurosci. Res. 2003;71:485-495.
2. Gibson, A., et al., Eur. J. Pharmacol. 2001;411:1-10.
3. Taniguchi, Y., et al., FEBS Lett. 2006;580:5003-5008.